Gongwin Biopharm Holdings Co., Ltd. (TPEX: 6617)

Gongwin Biopharm Holdings Market Cap

Gongwin Biopharm Holdings has a market cap or net worth of 13.96 billion as of November 22, 2024. Its market cap has decreased by -30.99% in one year.

• Market Cap: 13.96B
• Enterprise Value: 11.64B
• Revenue: 31.76M
• Ranking: n/a
• PE Ratio: n/a
• Stock Price: 109.50

Market Cap Chart

Since February 8, 2017, Gongwin Biopharm Holdings's market cap has increased from 8.87B to 13.96B, an increase of 57.47%. That is a compound annual growth rate of 6.00%.

Market Cap History

Date	Market Cap	% Change
Nov 20, 2024	13.64B	-34.75%
Dec 29, 2023	20.91B	-42.13%
Dec 30, 2022	36.13B	16.16%
Dec 30, 2021	31.10B	17.15%
Dec 31, 2020	26.55B	222.07%
Dec 31, 2019	8.24B	20.08%